Table 2.

Central retinal thickness (CRT) changes over 12 months of treatment with intravitreal ranibizumab for exudative age-related macular degeneration

Group	Before therapy	After therapy
		1 month	3 months	6 months	12 months
1	355.13±119.93	246.88±57.73	254.3±69.67	256.35±44.78	250.85±45.48
2	371.88±91.047	260.78±62.28	271.88±61.15	279.83±67.62	268.61±53.51
P*	0.204	0.233	0.046	0.074	0.079

Note:

^*P<0.05 was considered statistically significant.